---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012902"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:48:29.163710+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience FY2025: $24.7M cash, $20.8M equity proceeds; DARE to PLAY revenue expected Q2 2026

## Summary
- Cash and cash equivalents $24.7M at Dec 31, 2025; working capital $3.4M.
- Received $20.8M net from at-the-market equity program and equity line in 2025.
- Non-dilutive funding: $13.6M Gates Foundation, $4.5M ARPA-H, $1.3M NIH in 2025.
- SG&A $8.8M (down from $9.2M in 2024); R&D $5.5M (down from $14.3M); contra-R&D $16.4M from grants.
- Expects DARE to PLAY product revenue and Flora Sync LF5 consumer revenue to begin Q2 2026.

## SEC filing metadata
- accession: 0001493152-26-012902
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/0001493152-26-012902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012902
- JSON: https://secwatch.observer/filing/0001493152-26-012902.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012902.txt

## Key facts
- Earnings Releases
  Dare Bioscience, Inc. reported financial results for the year ended December 31, 2025.
  - Period: the year ended December 31, 2025
  - Result: reported results
  source text: On March 26, 2026, Daré Bioscience, Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2025, a copy of which is furnished as Exhibit 99.1 to this report.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401914/000149315226012902/0001493152-26-012902-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.